Search
TScan Therapeutics Inc
TCRXAdd to Watchlist
0.743USD
-0.013-1.68%
Close 07-31 16:00（ET）Quotes delayed by 15 min
42.28MMarket Cap
LossP/E TTM
TScan Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of TScan Therapeutics Inc is 8.78, ranking 58 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.78, which is -29.83% below the recent high of -0.54 and -1541.76% above the recent low of -12.74.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.